Pitvarfibrilláció: nyitott vizsgálatok itt: Hollandia
40 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. nov. 10.. Ask the study team whether a trial fits you.
No phaseToborozResearch participation
AI-Based Tools for Stroke Diagnosis, Treatment and Outcome Prediction: a Multicentre Prospective Observational Study
- Where
- Amsterdam, Rotterdam
- Age
- 18 év and over
- People
- 10 000 worldwide
- Run by
- Hospital Universitari Vall d'Hebron Research Institute
See details and how to joinNCT07924371Regiszter frissítve: 2026-11-09
3. fázisToborozTrial-stage medicine
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Where
- Amersfoort, Amstelveen, Amsterdam, Apeldoorn, Arnhem, Deventer, Dirksland, Doetinchem, Ede Gld, Groningen, Hardenberg, Harderwijk, Heerlen, Leiderdorp, Roosendaal, Rotterdam, Sneek, Tilburg, Zwolle
- Age
- 18 év and over
- People
- 15 364 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07626411EU 2025-521617-97-00Regiszter frissítve: 2026-11-05
2. fázisToborozTrial-stage medicine
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
- Where
- Arnhem, Delft, Goes, Groningen, Maastricht, Veldhoven
- Age
- 18 év and over
- People
- 165 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07217067Regiszter frissítve: 2026-10-28
2. fázisToborozTrial-stage medicine
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
- Where
- Groningen, Maastricht
- Age
- 18 év to 85 év
- People
- 360 worldwide
- Run by
- Bayer
See details and how to joinNCT07625215EU 2025-523807-31-00Regiszter frissítve: 2026-10-20
No phaseToborozResearch participation
The Multicenter Cardiology Monitoring Platform Registry
- Where
- Maastricht
- Age
- 16 év and over
- People
- 40 000
- Run by
- Maastricht University Medical Center
See details and how to joinNCT04976348Regiszter frissítve: 2026-10-19
No phaseToborozResearch participation
PulseSelect™ PFA Global Registry
- Where
- Nieuwegein
- Age
- 18 év and over
- People
- 1950 worldwide
- Run by
- Medtronic Cardiac Ablation Solutions
See details and how to joinNCT06393920Regiszter frissítve: 2026-10-16
3. fázisToborozTrial-stage medicine
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Where
- Amsterdam
- Age
- 18 év and over
- People
- 2628 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07430956EU 2025-521618-25-00Regiszter frissítve: 2026-10-14
2. fázisToborozResearch participation
A study to investigate the efficacy, safety, tolerability and pharmacokinetics of PKN605 in participants with atrial fibrillation
- Where
- Arnhem, Delft, Goes, Groningen, Haarlem, Maastricht, Veldhoven
- Age
- 18 év and over
- People
- 41 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-520518-79-00EU 2025-520518-79-00Regiszter frissítve: 2026-10-12
3. fázisToborozTrial-stage medicine
ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3
- Where
- Alkmaar, Almelo, Amstelveen, Apeldoorn, Arnhem, Beverwijk, Breda, Dirksland, Ede, Groningen, Hardenberg, Heerenveen, Heerlen, Helmond, Leeuwarden, Roosendaal, Rotterdam, 'S-Hertogenbosch
- Age
- 18 év and over
- People
- 750 worldwide
- Run by
- Milestone Pharmaceuticals Inc.
See details and how to joinNCT06716021EU 2024-516251-40-01Regiszter frissítve: 2026-10-07
2. fázisToborozTrial-stage medicine
Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
- Where
- Arnhem, Deventer, Groningen, Haarlem, Leeuwarden, Maastricht, 's-Gravenhage, Tiel, Veldhoven
- Age
- 18 év and over
- People
- 200 worldwide
- Run by
- Acesion Pharma
See details and how to joinNCT07267949EU 2025-521377-14-00Regiszter frissítve: 2026-09-30
No phaseToborozResearch participation
The Fourth Left Atrial Appendage Occlusion Study
- Where
- Eindhoven, Nieuwegein
- Age
- 18 év and over
- People
- 4000 worldwide
- Run by
- Hamilton Health Sciences Corporation
See details and how to joinNCT05963698Regiszter frissítve: 2026-09-18
No phaseToborzás még nem indultResearch participation
Lattice vs Pentaspline Comparative Evaluation in Persistent AF
- Where
- Rotterdam
- Age
- 18 év and over
- People
- 250 worldwide
- Run by
- Mitera Hospital
See details and how to joinNCT07815171Regiszter frissítve: 2026-09-15
4. fázisToborzás még nem indultResearch participation
Alert-HF: Early Detection and Intervention on Atrial Fibrillation in Heart Failure Patients
- Where
- Enschede
- Age
- 18 év and over
- People
- 258
- Run by
- Medisch Spectrum Twente
See details and how to joinNCT07816458Regiszter frissítve: 2026-09-11
No phaseToborozResearch participation
Detection of Atrial Fibrillation Using PPG From Smartphone Cameras
- Where
- Zwolle
- Age
- 22 Minutes and over
- People
- 554 worldwide
- Run by
- Happitech BV
See details and how to joinNCT07779213Regiszter frissítve: 2026-08-21
No phaseToborozResearch participation
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
- Where
- Nieuwegein
- Age
- 18 év to 80 év
- People
- 360 worldwide
- Run by
- Arga Medtech SA
See details and how to joinNCT06784466Regiszter frissítve: 2026-07-15
No phaseToborozResearch participation
Optimized Expansion of the Implanted Transcatheter Aortic Valve
- Where
- Amsterdam, Groningen, Leiden, Nieuwegein
- Age
- 18 év and over
- People
- 1010 worldwide
- Run by
- Ole De Backer
See details and how to joinNCT07042529Regiszter frissítve: 2026-07-10
3. fázisToborozResearch participation
SACK
- Where
- Nieuwegein
- Age
- 18 év and over
- People
- 1281 worldwide
- Run by
- Karolinska University Hospital
See details and how to join2022-501600-10-00EU 2022-501600-10-00Regiszter frissítve: 2026-06-23
No phaseToborozResearch participation
Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention
- Where
- Heerlen
- Age
- 18 év and over
- People
- 1270
- Run by
- Zuyderland Medisch Centrum
See details and how to joinNCT04977076Regiszter frissítve: 2026-05-29
No phaseToborzás még nem indultResearch participation
AV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation
- Where
- Groningen, Leeuwarden, Maastricht, Nieuwegein, 's-Hertogenbosch
- Age
- 18 év and over
- People
- 292 worldwide
- Run by
- University Medical Center Groningen
See details and how to joinNCT07604727Regiszter frissítve: 2026-05-22
No phaseToborozResearch participation
Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation
- Where
- Nieuwegein
- Age
- 18 év to 110 év
- People
- 2500
- Run by
- St. Antonius Hospital
See details and how to joinNCT06168370Regiszter frissítve: 2026-05-19
3. fázisToborozResearch participation
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
- Where
- Amsterdam, Nijmegen, 's-Gravenhage, Utrecht
- Age
- 18 év and over
- People
- 1746 worldwide
- Run by
- Universitätsklinikum Hamburg-Eppendorf
See details and how to joinNCT05293080EU 2025-521260-35-00Regiszter frissítve: 2026-05-18
4. fázisToborozTrial-stage medicine
Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
- Where
- Amsterdam
- Age
- 18 év and over
- People
- 3010 worldwide
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT05955365Regiszter frissítve: 2026-05-08
No phaseToborozResearch participation
The MAGiC™ Cardiac Ablation European Study
- Where
- Rotterdam
- Age
- 18 év and over
- People
- 150 worldwide
- Run by
- Stereotaxis
See details and how to joinNCT06019845Regiszter frissítve: 2026-05-04
4. fázisToborozTrial-stage medicine
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
- Where
- Alkmaar, Almelo, Amstelveen, Arnhem, Breda, Deventer, Ede, Groningen, Rotterdam, 's-Hertogenbosch, Tilburg
- Age
- 55 év and over
- People
- 2270 worldwide
- Run by
- Population Health Research Institute
See details and how to joinNCT03968393EU 2023-509142-35-00Regiszter frissítve: 2026-01-12
No phaseToborozResearch participation
CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation
- Where
- Amsterdam, Eindhoven, Maastricht, Nieuwegein
- Age
- 18 év to 85 év
- People
- 30 worldwide
- Run by
- Pulse Biosciences, Inc.
See details and how to joinNCT06355063Regiszter frissítve: 2026-01-12
Minden vizsgálat (Pitvarfibrilláció) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.